Akums Drugs and Pharmaceuticals Limited
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
20.70 INR
3.38 B INR
41.18 B INR
31.66 M
About Akums Drugs and Pharmaceuticals Limited
Sector
Industry
Website
Headquarters
New Delhi
Founded
2004
Identifiers
2
ISININE09XN01023
Akums Drugs & Pharmaceuticals Ltd. engages in the manufacturing and marketing of pharmaceutical products and services. It operates segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), and Branded and Generic Formulations. The CDMO segment involves in the formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on contract basis, job work and testing services. The API segment is engaged in manufacturing and sale of KSM, Intermediate and API products. The Branded and Generic Formulations segment is engaged in marketing and distribution of branded and generic pharmaceutical formulations. The firm’s products include tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid syrups and suspensions, injections, eye/ear drops, ayurveda and herbal preparations, nutraceutical, and cosmetic preparations. The company was founded by Sanjeev Jain and Sandeep Jain on April 19, 2004 and is headquartered in New Delhi, India.
Related stocks
$AKUMrun it back turbo from here pls
who ever is loading up and trying to shake people out
good job
lets flip range high from here and start the fun
still got a long term outlook no rush just gutted added a bit too early again
AKUMS DRUGS AND PHARMA LTD S/RSupport and Resistance Levels:
Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
$akum drugs and pharmasorry but i have sinned swapped my jio F for this for now
trying to be greedy and to be honest not worried with it long term so for now waiting on some volume to kick in as the promoter stops supressing price and we fly
expect new orders in a few months to boost its rating either way we go up rs
Trendline Breakout - AKUMS
AKUMS:
Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.
Technical Analysis:
Current Price: Trading at ₹558.
AKUMS : Breakout Candidate#AKUMS #breakoutstock #breakout
AKUMS : Swing Trade
>> Breakout Expected
>> Good Strenght & Volumes
>> Low Risk High Reward Trade
>> Upside Potential 15%
Swing Traders can lock Profit at 10% & keep trailing
Disc : Charts shared for Study Purpose only
$akumdrugsandpharmaanother multibagger on a key reclaim imo
targeting new ath shall obviously take some off the table at range high
this is one volatile stock so do not let the scare you its been included in small cap index so should do well along with new orders coming in from europe
$akumsadded some more here although went heavier in Jio F but would have been rude not to add to this since am a fair bit down
CDMO space is set to grow so this should as well .simples.
IPO listing pattern of pump dump and make people cry is almost over imo
yellow line above is where vwap is from at
AKUMSDisclaimer:
This is not financial advice. Please do your own research or consult with a financial advisor before making any investment decisions. Investments in stocks can be risky and may result in loss of capital.
$AKUMDRUGSANDPHARMAcan not make any sense of this considering its profit was up and looks to be a decent company
anyways thought it would be rude not to add here since fear is at its peak
rsi curling up 616 next gap to fill then 725 is the key level for things to return to normal
lowered my avg entry so can rea
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MOSMALL250
Motilal Oswal Nifty Smallcap 250 ETF Units Exchange Traded FundWeight
0.06%
Market value
8.60 K
USD
MULTICAP
Mirae Asset Nifty500 Multicap 502525 ETF Exchange Traded Fund UnitsWeight
0.01%
Market value
816.72
USD
Explore more ETFs
Frequently Asked Questions
The current price of AKUMS is 446.30 INR — it has decreased by −0.58% in the past 24 hours. Watch Akums Drugs and Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Akums Drugs and Pharmaceuticals Limited stocks are traded under the ticker AKUMS.
AKUMS stock has risen by 6.84% compared to the previous week, the month change is a 6.65% rise, over the last year Akums Drugs and Pharmaceuticals Limited has showed a −25.37% decrease.
We've gathered analysts' opinions on Akums Drugs and Pharmaceuticals Limited future price: according to them, AKUMS price has a max estimate of 740.00 INR and a min estimate of 600.00 INR. Watch AKUMS chart and read a more detailed Akums Drugs and Pharmaceuticals Limited stock forecast: see what analysts think of Akums Drugs and Pharmaceuticals Limited and suggest that you do with its stocks.
AKUMS reached its all-time high on Aug 20, 2024 with the price of 1,175.90 INR, and its all-time low was 405.00 INR and was reached on Apr 7, 2025. View more price dynamics on AKUMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AKUMS stock is 1.85% volatile and has beta coefficient of 1.71. Track Akums Drugs and Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Akums Drugs and Pharmaceuticals Limited there?
Today Akums Drugs and Pharmaceuticals Limited has the market capitalization of 71.01 B, it has decreased by −0.39% over the last week.
Yes, you can track Akums Drugs and Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Akums Drugs and Pharmaceuticals Limited is going to release the next earnings report on Feb 5, 2026. Keep track of upcoming events with our Earnings Calendar.
AKUMS net income for the last quarter is 407.83 M INR, while the quarter before that showed 634.75 M INR of net income which accounts for −35.75% change. Track more Akums Drugs and Pharmaceuticals Limited financial stats to get the full picture.
No, AKUMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2025, the company has 17.86 K employees. See our rating of the largest employees — is Akums Drugs and Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Akums Drugs and Pharmaceuticals Limited EBITDA is 4.39 B INR, and current EBITDA margin is 11.25%. See more stats in Akums Drugs and Pharmaceuticals Limited financial statements.
Like other stocks, AKUMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Akums Drugs and Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Akums Drugs and Pharmaceuticals Limited technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Akums Drugs and Pharmaceuticals Limited stock shows the buy signal. See more of Akums Drugs and Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.